APA (7th ed.) Citation

Mohty, R., Bazarbachi, A. H., Labopin, M., Esteve, J., Kröger, N., Cornelissen, J. J., . . . Mohty, M. (2024). Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: A study of the ALWP of the EBMT. Bone marrow transplantation, 59(11), . https://doi.org/10.1038/s41409-024-02384-2

Chicago Style (17th ed.) Citation

Mohty, Razan, et al. "Isocitrate Dehydrogenase (IDH) 1 and 2 Mutations Predict Better Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation: A Study of the ALWP of the EBMT." Bone Marrow Transplantation 59, no. 11 (2024). https://doi.org/10.1038/s41409-024-02384-2.

MLA (9th ed.) Citation

Mohty, Razan, et al. "Isocitrate Dehydrogenase (IDH) 1 and 2 Mutations Predict Better Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation: A Study of the ALWP of the EBMT." Bone Marrow Transplantation, vol. 59, no. 11, 2024, https://doi.org/10.1038/s41409-024-02384-2.